SE7902521L - Fenylketoner - Google Patents

Fenylketoner

Info

Publication number
SE7902521L
SE7902521L SE7902521A SE7902521A SE7902521L SE 7902521 L SE7902521 L SE 7902521L SE 7902521 A SE7902521 A SE 7902521A SE 7902521 A SE7902521 A SE 7902521A SE 7902521 L SE7902521 L SE 7902521L
Authority
SE
Sweden
Prior art keywords
mouse
amino acid
lower alkyl
anticonvulsant
alkyl
Prior art date
Application number
SE7902521A
Other languages
English (en)
Other versions
SE438152B (sv
Inventor
C H Hassall
W H Johnson
A Krohn
C E Smithen
W A Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB36567/74A external-priority patent/GB1517164A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7902521L publication Critical patent/SE7902521L/sv
Publication of SE438152B publication Critical patent/SE438152B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
SE7902521A 1974-08-20 1979-03-20 Forfarande for framstellning av substituerade fenylketoner med sedativ, muskelrelaxerande och antikonvulsiv verkan SE438152B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB36567/74A GB1517164A (en) 1974-08-20 1974-08-20 Substituted-phenyl ketones and a process for the manufacture thereof

Publications (2)

Publication Number Publication Date
SE7902521L true SE7902521L (sv) 1979-03-20
SE438152B SE438152B (sv) 1985-04-01

Family

ID=10389314

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7902522A SE438153B (sv) 1974-08-20 1979-03-20 Forfarande for framstellning av l-lysyl-n-(2-bensoyl-4-klorfenyl)-n-metylglycinamid med sedativ, muskelrelaxerande och antikonvulsiv verkan
SE7902521A SE438152B (sv) 1974-08-20 1979-03-20 Forfarande for framstellning av substituerade fenylketoner med sedativ, muskelrelaxerande och antikonvulsiv verkan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7902522A SE438153B (sv) 1974-08-20 1979-03-20 Forfarande for framstellning av l-lysyl-n-(2-bensoyl-4-klorfenyl)-n-metylglycinamid med sedativ, muskelrelaxerande och antikonvulsiv verkan

Country Status (5)

Country Link
JP (1) JPS58150549A (sv)
BE (1) BE832532A (sv)
FR (1) FR2315914A1 (sv)
SE (2) SE438153B (sv)
ZA (1) ZA755197B (sv)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181065A (en) * 1974-08-06 1985-01-15 Kentaro Hirai Dipeptide derivatives and their production

Also Published As

Publication number Publication date
JPS58150549A (ja) 1983-09-07
SE7902522L (sv) 1979-03-20
ZA755197B (en) 1976-07-28
JPS6259120B2 (sv) 1987-12-09
BE832532A (fr) 1976-02-19
SE438153B (sv) 1985-04-01
SE438152B (sv) 1985-04-01
FR2315914B1 (sv) 1978-11-17
FR2315914A1 (fr) 1977-01-28

Similar Documents

Publication Publication Date Title
SE8900130D0 (sv) Konceptet att med hjaelp av molekylavtrycksmetoden framstaella konstgjorda antikroppar genom imprinting av t ex antigener samt att framstaella konstgjorda entzymer genom imprintning med transition state analoger
GB1150445A (en) Hair Dyeing Compositions and Nitro Dyes for use therein
MX9207270A (es) Compuestos de haluro de amonio y metodo para su preparacion.
ES2043781T3 (es) Un procedimiento para la preparacion de nuevos derivados de 2beta-morfolino-androstano.
ES8402297A1 (es) Un procedimiento de preparacion de derivados de imidazo-(1,2-)piridina.
FR2439199A1 (fr) Pyrido(2,1-b)quinazolones et medicaments qui en contiennent
SE7902521L (sv) Fenylketoner
BR8200949A (pt) Imidazodiazepinas,substancias farmaceutica ativas,processo para a fabricacao de compostos,medicamentos,medicamento esquistossomicidamente ativo e uso de compostos
ES8602028A1 (es) Procedimiento para la obtencion de derivados del acido meti-lendifosfonico
MC1575A1 (fr) Nouveau derives de la guanine
BR9503810A (pt) Arilbenzoilguanidinas processo para a preparação de derivados de arilbenzoilguanidinas processo para a produção de preparações farmacêuticas preparação farmacêutica e uso
ES8604593A1 (es) Un procedimiento para preparar derivados de imidazo(1,2-a) quinoleinas
NL7900157A (nl) Nieuwe aminoderivaten van pyrazolo 1.5-a s.triazine, werkwijze ter bereiding daarvan en toepassing daarvan in farmaceutische preparaten.
ES534414A0 (es) Un procedimiento para preparar pirazolo (3, 4, 5-kl) acridinas
Chello et al. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
IT1156732B (it) Derivati sostituiti dell'1,3-diidroimidazo(4,5-b)piridin-2-one e relativo procedimento di produzione
FR2421869A1 (fr) Nouvelles paraphenylenediamines substituees, et compositions tinctoriales les contenant
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
DE3864428D1 (de) Haarfaerbemittel mit direktziehenden nitrodiphenylamin-derivaten.
ES520800A0 (es) Un procedimiento para la preparacion de derivados del acido 2-o 4-tiazolidincarboxilico 3-acil substituidos.
DE3779738D1 (de) Amycin und dessen derivate, verfahren zu deren herstellung und deren verwendung.
ATA749277A (de) Verfahren zur herstellung von neuen 6-(m- -aminophenyl)-2,3,5,6-tetrahydroimidazo(2,1-b) thiazolderivaten und von deren salzen
GB1375157A (sv)
FR2296422A1 (fr) Nouveaux amides derives de la theophylline, leur procede de preparation
HUT37382A (en) New salts of cyclopropanecarboxylic acid and their application

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7902521-9

Effective date: 19890911

Format of ref document f/p: F